Buchumschlag

Host-directed therapies for bacterial and viral infections

Despite the recent increase in the development of antivirals and antibiotics, antimicrobial resistance and the lack of broad-spectrum virus-targeting drugs are still important issues and additional alternative approaches to treat infectious diseases are urgently needed. Host-directed therapy (HDT) i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kaufmann, Stefan H. E. (VerfasserIn) , Bartenschlager, Ralf (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2018
In: Nature reviews. Drug discovery
Year: 2017, Jahrgang: 17, Heft: 1, Pages: 35-56
ISSN:1474-1784
DOI:10.1038/nrd.2017.162
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1038/nrd.2017.162
Verlag, Volltext: https://www.nature.com/articles/nrd.2017.162
Volltext
Verfasserangaben:Stefan H.E. Kaufmann, Anca Dorhoi, Richard S. Hotchkiss, Ralf Bartenschlager

MARC

LEADER 00000caa a2200000 c 4500
001 1577753712
003 DE-627
005 20230426230709.0
007 cr uuu---uuuuu
008 180719r20182017xx |||||o 00| ||eng c
024 7 |a 10.1038/nrd.2017.162  |2 doi 
035 |a (DE-627)1577753712 
035 |a (DE-576)507753712 
035 |a (DE-599)BSZ507753712 
035 |a (OCoLC)1341013948 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kaufmann, Stefan H. E.  |d 1948-  |e VerfasserIn  |0 (DE-588)112059252  |0 (DE-627)499566173  |0 (DE-576)166249750  |4 aut 
245 1 0 |a Host-directed therapies for bacterial and viral infections  |c Stefan H.E. Kaufmann, Anca Dorhoi, Richard S. Hotchkiss, Ralf Bartenschlager 
264 1 |c 2018 
300 |a 22 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published online 22 Sept 2017 
500 |a Gesehen am 19.07.2018 
520 |a Despite the recent increase in the development of antivirals and antibiotics, antimicrobial resistance and the lack of broad-spectrum virus-targeting drugs are still important issues and additional alternative approaches to treat infectious diseases are urgently needed. Host-directed therapy (HDT) is an emerging approach in the field of anti-infectives. The strategy behind HDT is to interfere with host cell factors that are required by a pathogen for replication or persistence, to enhance protective immune responses against a pathogen, to reduce exacerbated inflammation and to balance immune reactivity at sites of pathology. Although HDTs encompassing interferons are well established for the treatment of chronic viral hepatitis, novel strategies aimed at the functional cure of persistent viral infections and the development of broad-spectrum antivirals against emerging viruses seem to be crucial. In chronic bacterial infections, such as tuberculosis, HDT strategies aim to enhance the antimicrobial activities of phagocytes and to curtail inflammation through interference with soluble factors (such as eicosanoids and cytokines) or cellular factors (such as co-stimulatory molecules). This Review describes current progress in the development of HDTs for viral and bacterial infections, including sepsis, and the challenges in bringing these new approaches to the clinic. 
534 |c 2017 
700 1 |a Bartenschlager, Ralf  |d 1958-  |e VerfasserIn  |0 (DE-588)1058097989  |0 (DE-627)796390509  |0 (DE-576)168706067  |4 aut 
773 0 8 |i Enthalten in  |t Nature reviews. Drug discovery  |d London : Nature Publ. Group, 2002  |g 17(2018), 1, Seite 35-56  |h Online-Ressource  |w (DE-627)336452497  |w (DE-600)2061062-2  |w (DE-576)100800629  |x 1474-1784  |7 nnas  |a Host-directed therapies for bacterial and viral infections 
773 1 8 |g volume:17  |g year:2018  |g number:1  |g pages:35-56  |g extent:22  |a Host-directed therapies for bacterial and viral infections 
856 4 0 |u http://dx.doi.org/10.1038/nrd.2017.162  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/nrd.2017.162  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180719 
993 |a Article 
994 |a 2018 
998 |g 1058097989  |a Bartenschlager, Ralf  |m 1058097989:Bartenschlager, Ralf  |d 910000  |d 911700  |e 910000PB1058097989  |e 911700PB1058097989  |k 0/910000/  |k 1/910000/911700/  |p 4  |y j 
999 |a KXP-PPN1577753712  |e 3018315960 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"name":{"displayForm":["Stefan H.E. Kaufmann, Anca Dorhoi, Richard S. Hotchkiss, Ralf Bartenschlager"]},"title":[{"title_sort":"Host-directed therapies for bacterial and viral infections","title":"Host-directed therapies for bacterial and viral infections"}],"recId":"1577753712","id":{"eki":["1577753712"],"doi":["10.1038/nrd.2017.162"]},"relHost":[{"note":["Gesehen am 11.01.2019"],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2061062-2"],"issn":["1474-1784"],"eki":["336452497"]},"titleAlt":[{"title":"Nature reviews / Drug discovery"},{"title":"Drug discovery"}],"origin":[{"dateIssuedKey":"2002","publisher":"Nature Publ. Group","dateIssuedDisp":"2002-","publisherPlace":"London"}],"title":[{"partname":"Drug discovery","title":"Nature reviews","title_sort":"Nature reviews"}],"disp":"Host-directed therapies for bacterial and viral infectionsNature reviews. Drug discovery","recId":"336452497","language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.2002 -"],"part":{"year":"2018","text":"17(2018), 1, Seite 35-56","pages":"35-56","extent":"22","issue":"1","volume":"17"}}],"origin":[{"dateIssuedDisp":"2018","dateIssuedKey":"2018"}],"note":["Published online 22 Sept 2017","Gesehen am 19.07.2018"],"person":[{"display":"Kaufmann, Stefan H. E.","role":"aut","given":"Stefan H. E.","roleDisplay":"VerfasserIn","family":"Kaufmann"},{"role":"aut","display":"Bartenschlager, Ralf","given":"Ralf","family":"Bartenschlager","roleDisplay":"VerfasserIn"}],"physDesc":[{"extent":"22 S."}]} 
SRT |a KAUFMANNSTHOSTDIRECT2018 

Ähnliche Einträge